FDA, Trump and Psychedelics
Digest more
The FDA meeting announcement follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on ...
The Food and Drug Administration on Wednesday announced meeting dates for advisors to discuss lifting restrictions on 12 ...
A widely prescribed anxiety medication is being pulled from shelves nationwide after a quality issue triggered a recall from ...
Estrogen patches, one of the most popular menopause treatments, have been in short supply this year. Now the FDA is working ...
Health Secretary Robert F. Kennedy Jr. is a self-professed "big fan" of peptides. They have grown in popularity for wellness ...
Certain people "run the risk of a serious or life-threatening allergic reaction if they consume this product," the firm ...
The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide ...
A safety alert came on Friday after health officials in Washington State reported illnesses associated with the consumption ...
In 1938, Congress passed the Federal Food, Drug, and Cosmetic Act (FD&C Act), which gave the Food and Drug Administration ...
Viatris Specialty LLC initiated a nationwide retail-level recall of Xanax XR extended-release tablets, the company said in a ...
The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results